New Launch20 Nov 2025, 01:22 pm
Marksans Pharma's Subsidiary Secures Marketing Authorisation in UK
AI Summary
Marksans Pharma Limited's wholly owned subsidiary, Relonchem Limited, has received Marketing Authorisation for its product Cetirizine Dihydrochloride 1 mg/ml Oral Solution from the UK Medicines and Healthcare products Regulatory Agency (MHRA). This authorisation marks a significant step for Marksans Pharma in expanding its reach in the UK market.
Key Highlights
- Marksans Pharma's subsidiary, Relonchem Limited, receives Marketing Authorisation for Cetirizine Dihydrochloride 1 mg/ml Oral Solution
- Authorisation received from UK MHRA
- Marksans Pharma continues to expand its presence in the UK market